Hedge Funds Are Selling Avalanche Biotechnologies Inc (AAVL)
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don't make them change their ...
Posts Tagged ‘NASDAQ:AAVL’
VHCP Management Produced Impressive Returns From Its Pharma Stock Picks In The Turbulent Third Quarter
With losses in the high single-digits and volatility hitting the roof, the third quarter of 2015 turned out to be a troublesome period for the equity markets.
Deerfield Management Trims Holding In Antares Pharma Inc (ATRS) Just Before Disastrous Setback
According to a recent filing with the Securities and Exchange Commission, James E.
Zimmer Holdings Inc. (ZMH), Avalanche Biotechnologies Inc (AAVL), Wright Medical Group Inc (WMGI): Ghost Tree Capital’s Top Biotech Stocks
David Kim and Ken Greenberg’s Ghost Tree Capital has filed its most recent 13F with the SEC recently, and we poured through it to analyze the fund’s newest picks and top plays...
Juno Therapeutics Inc (JUNO), Anacor Pharmaceuticals Inc (ANAC): VHCP Management’s Top 3 Biotech Picks
Andres Hove and Bong Koh’s VHCP Management revealed its top 3 biotech picks heading into 2015, in a 13F Form filed with the U.S.
Biotech Hedge Fund Deerfield Management’s Top Stock Picks
James E. Flynn's Deerfield Management is one of the funds that is focused on the healthcare sector, investing around 70% of its portfolio in healthcare stocks.
Avalanche Biotechnologies Inc (AAVL), Anacor Pharmaceuticals Inc (ANAC), DBV Technologies, Boulogne-Billancourt (DBVT): Among Venrock’s Top Succesful Biotech Plays
Venrock Healthcare Capital Partners is a fund that is focused entirely on the healthcare sector, mainly on the biotech sector.
